Relationship between in vivo and in vitro activity of terbinafine against Microsporum canis infection in cats

Journal de Mycologie Medicale

Volumn 10, Issue 1, 2000, Pages 30-33

  Millanta, F ^a   Pedonese, F ^a   Mancianti, F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Microsporum canis; Susceptibility; Terbinafine

Indexed keywords

TERBINAFINE;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CAT; CAT DISEASE; CONTROLLED STUDY; DERMATOMYCOSIS; DRUG EFFICACY; FEMALE; FUNGUS CULTURE; MALE; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0034056950     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Balfour JA, Faulds D. Terbinafine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992;43:259-84.
2. Bille J. Correlation between in vitro and in vivo activity of antifungal agents against yeasts. J Mycol Méd 1996;6:118-22.
3. Birnbaum JE. Concluding remarks. Dermatology 1997;194 (suppl. 1):48-9.
4. Carlotti DN. Dermatophytosis, part 2-Diagnosis and therapy. Third World Congress of Veterinary Dermatology. Clinical Programme, Edinburgh, Scotland, UK, 11-14 September 1996, pp. 37-43.
5. Clayton YM. In vitro activity of terbinafine. Clin Exp Dermatol 1989;14:101-3.
6. Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Brit J Dermatol 1994;130:7-8.
7. Ellis DH, Marley JE, Watson AB, Williams TG. Significance of non-dermatophyte moulds and yeasts in onychomycosis. Dermatology 1997;194 (suppl 1):40-2.
8. Espinel-Ingroff A. Antifungal susceptibility testing. Clin Microbiol Newsl 1996;18:161-8.
9. Faegermann J, Zehender H, Jones T, Maibach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (whithout stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol 1990;71:322-6.
10. Georgii A, Korting HC. Antifungal susceptibility testing with dermatophytes. Mycoses 1991;34:193-9.
11. Korting HC, Georgii A. Antimycotikatestung dermatovenerologisch bedeutsamer Hefen: Methoden, Ergebnisse und klinische Relevanz. Hautarzt 1988;39:343-7.
12. Mancianti F, Zullino C, Papini R. Itraconazole susceptibility of feline isolates of Microsporum canis. Mycoses 1997;40:313-5.
13. Mancianti F, Pedonese F, Millanta F, Guarnieri L. Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis. J Feline Med Surg 1999;1:37-41.
14. Mc Kenzie DWR. Hairbrush diagnosis in detection and eradication of non fluorescent scalp ringworm. Brit Med J 1963;2:363-5.
15. Meinhof W. Kinetics and spectrum of activity of oral antifungals: the therapeutic implications. J Am Acad Dermatol 1993;29;S37-S41.
16. Mieth H, Leitner I, Meingassner JG. The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses. J Med Vet Mycol 1994;32:81-8.
17. Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 1998;197:361-7.
18. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, PA 1992.
19. Petranyi G, Meingassner JG, Mieth H. Activity of terbinafine in experimental fungal infections of laboratory animals. Antimicrob Agents Chemother 1987;31:1558-61.
20. Rebell G, Taplin D. Dermatophytes: their recognition and identification. University of Miami Press, Coral Gables, Florida (1979), pp. 13-14.
21. Roberts DT. Oral terbinafine (Lamisil®) in the treatment of fungal infections of the skin and nails. Dermatology 1997;194 (suppl 1):37-9.
22. Stillers MJ. Systemic drugs in the treatment of dermatophytoses. Int J Dermatol 1993;32:16-21.
23. Wright LR, Scott EM, Gorman SP. The sensitivity of mycelium, arthrospores and microconidia of Trichophyton mentagrophytes to imidazoles determined by in vitro tests. J Antimicrob Chemother 1983;12:317-27.